S&P 500

5.640,35

0,16%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Notícias

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
10/11/2008	12:17	Business Wire	Four Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of Hematology	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/11/2008	20:09	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/11/2008	19:05	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/11/2008	19:00	Business Wire	Allos Therapeutics Reports 2008 Third Quarter Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/11/2008	11:00	Business Wire	Allos Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/10/2008	18:00	Business Wire	Four Pralatrexate (PDX) Studies Accepted for Presentation at the 50th Annual Meeting of the American Society of Hematology	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/10/2008	10:00	Business Wire	Allos Therapeutics to Report Third Quarter 2008 Results on November 5, 2008	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/10/2008	09:00	Business Wire	Allos Therapeutics to Present at the JMP Healthcare Focus Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/09/2008	10:05	Edgar (US Regulatory)	Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/09/2008	18:06	Edgar (US Regulatory)	Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
02/09/2008	09:00	Business Wire	Allos Therapeutics to Present at the 3rd Annual Citi Biotech Day	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/08/2008	17:00	Business Wire	Allos Therapeutics to Present at the NewsMakers in the Biotech Industry Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/08/2008	17:17	Edgar (US Regulatory)	Allos Therapeutics Inc - Amended Annual Report (10-K/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/08/2008	18:30	Edgar (US Regulatory)	Allos Therapeutics Inc - Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/08/2008	17:03	Edgar (US Regulatory)	Allos Therapeutics Inc - Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/08/2008	17:00	Business Wire	Allos Therapeutics Reports 2008 Second Quarter Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/07/2008	09:00	Business Wire	Allos Therapeutics to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/07/2008	09:00	Business Wire	Allos Therapeutics to Report Second Quarter 2008 Results on August 5, 2008	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/07/2008	09:00	Business Wire	Allos Therapeutics Initiates Phase 2 Study of PDX in Patients with Advanced or Metastatic Relapsed Transitional Cell Carcinoma o	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/07/2008	09:00	Business Wire	Allos Therapeutics to Present at the Collins Stewart Fourth Annual Growth Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/06/2008	16:55	Edgar (US Regulatory)	Allos Therapeutics Inc - Securities Registration: Employee Benefit Plan (S-8)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/06/2008	16:52	Edgar (US Regulatory)	Allos Therapeutics Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/06/2008	08:00	Business Wire	Allos Therapeutics to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/06/2008	16:00	Business Wire	Allos Therapeutics Announces Interim Data from Phase 1 Study of PDX in Patients with Relapsed or Refractory Cutaneous T-Cell Lym	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/05/2008	17:05	Edgar (US Regulatory)	Allos Therapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/05/2008	12:15	Edgar (US Regulatory)	Allos Therapeutics Inc - Statement of Ownership (SC 13G)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/05/2008	16:00	Business Wire	Allos Therapeutics Announces Closing of Public Common Stock Offering	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/05/2008	08:25	Edgar (US Regulatory)	Allos Therapeutics Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/05/2008	08:15	Edgar (US Regulatory)	Allos Therapeutics Inc - Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/05/2008	07:34	Business Wire	Allos Therapeutics Announces Pricing of Public Offering of 10,800,000 Shares of Common Stock	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)